Related Experiment Video
Updated: Jun 30, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Propofol infusion syndrome
Carol Rajda1, Darlene Dereczyk, Patti Kunkel
1Department of Trauma Services, Henry Ford Hospital, Detroit, Michigan 48202, USA. crajda1@hfhs.org
Propofol infusion syndrome (PRIS) is a rare but fatal complication of high-dose propofol infusions. Early identification, prevention, and prompt treatment are crucial for improving patient outcomes and survival rates.
Area of Science:
- Anesthesiology
- Critical Care Medicine
Background:
- Propofol is a widely used intravenous sedative-hypnotic for anesthesia induction and maintenance.
- High-dose propofol infusions can lead to serious adverse effects, collectively termed propofol infusion syndrome (PRIS).
Purpose of the Study:
- To enhance practitioner awareness of propofol infusion syndrome (PRIS).
- To provide recommendations for the early identification, prevention, and treatment of PRIS.
Main Methods:
- This article reviews existing literature and clinical guidelines on PRIS.
- It synthesizes information to create practical recommendations for healthcare providers.
Main Results:
- PRIS is a rare but frequently fatal condition if not recognized early.
- Early recognition and intervention significantly improve patient prognosis.
Conclusions:
- Increased practitioner awareness of PRIS is essential.
- Implementing recommended strategies for identification, prevention, and treatment can mitigate the risks associated with high-dose propofol infusions.
Related Concept Videos
Parenteral Anesthetics: Overview
IV Infusion to Oral Dosing: Conversion Methods
Stages of General Anesthesia
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Inhalational Anesthetics: Overview
One-Compartment Open Model for IV Bolus Administration: General Considerations
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant, half-life,...
